Hepatitis B
📧 Sign up to get email alerts when something new happens for Hepatitis B.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2008-12-30Clinical Trial Update: A Single-Arm Study Evaluating the Efficacy of Liquid Acupuncture Therapeutics in Chronic Hepatitis B [NA]
A single-arm clinical trial evaluated the efficacy of Liquid Acupuncture Therapeutics for chronic hepatitis B.
-
CLINICAL_TRIALS trial_result · 2008-12-18Clinical Trial Update: Influence of Antiviral Treatment to the Long-Term Prognosis of Patients With Chronic HBV Infection [Phase 4]
This Phase 4 clinical trial update investigates whether antiviral treatment affects the long-term prognosis of patients with chronic hepatit…
-
CLINICAL_TRIALS trial_result · 2008-12-02Clinical Trial Update: Studies of Immune Responses in Patients With Chronic Hepatitis B
A completed clinical trial update examining immune responses in patients with chronic hepatitis B.
-
CLINICAL_TRIALS trial_result · 2008-11-21Clinical Trial Update: Safety Study of HBV DNA Vaccine to Treat Patients With Chronic Hepatitis B Infection [Phase 1]
Phase 1 safety study of an HBV DNA vaccine for chronic hepatitis B has completed.
-
EMA withdrawal · 2008-11-19EMA Withdrawn: Viraferon (interferon alfa-2b) — Schering-Plough Europe
EMA withdrawal of Viraferon (interferon alfa-2b) by Schering-Plough Europe for chronic hepatitis B and C.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2008-10-24Clinical Trial Update: Different Regimens of Pegylated Interferon and Lamivudine Combination Therapy in Chronic Hepatitis B Patients [Phase 2]
This ClinicalTrials.gov entry reports results from a Phase 2 study evaluating different regimens of pegylated interferon in combination with…
-
CLINICAL_TRIALS trial_result · 2008-10-16Clinical Trial Update: Lamivudine Plus Interferon Versus Lamivudine For The Treatment Of HBeAg Positive Chronic Hepatitis B Virus (HBV) [Phase 3]
Phase 3 study comparing lamivudine plus interferon versus lamivudine for HBeAg-positive chronic hepatitis B has completed.
-
CLINICAL_TRIALS trial_result · 2008-10-01Clinical Trial Update: Safety of and Immune Response to a Hepatitis B Virus Vaccine Given With a Booster (CpG7909 ODN) in HIV Infected and HIV Uninfected People [Phase 1, Phase 2]
This completed Phase 1/2 trial evaluated the safety and immune response of a Hepatitis B vaccine given with a CpG7909 ODN booster in adults …
-
EMA withdrawal · 2008-09-10EMA Withdrawn: Quintanrix (Diphtheria toxoid;tetanus toxoid;inactivated Bordetella pertussis;hepatitis B surface antigen (rDNA);Haemophilus influenzae type b polysaccharide) — GlaxoSmithKline Biologicals S.A.
Quintanrix has been withdrawn from the market by GlaxoSmithKline Biologicals S.A., with the status indicating withdrawal for its diphtheria,…
-
CLINICAL_TRIALS trial_result · 2008-09-05Clinical Trial Update: Laboratory Profile of Hepatitis B and C in Users of a Reference Service
A completed clinical trial update describing laboratory findings for Hepatitis B and Hepatitis C among users of a reference laboratory servi…
-
CLINICAL_TRIALS trial_result · 2008-08-28Clinical Trial Update: A Study to Compare the Immune Response and Safety Elicited by Henogen's Adjuvanted Hepatitis B Vaccine Compared to Aventis Pasteur MSD's Hepatitis B Vaccine in Pre-Dialysis and Dialysis Patients Who Responded to Previous Hepatitis B Vaccination But Lost Antibody. [Phase 3]
Phase 3 trial comparing Henogen's adjuvanted Hepatitis B vaccine to Aventis Pasteur MSD's Hepatitis B vaccine in pre-dialysis and dialysis p…
-
CLINICAL_TRIALS trial_result · 2008-08-28Clinical Trial Update: Compare the Immune Response & Safety Elicited by Henogen's Adjuvanted Hepatitis B Vaccine vs Aventis Pasteur MSD's Hepatitis B Vaccine in Pre-Dialysis & Dialysis Patients Who Did Not Respond to Previous Hepatitis B Vaccination [Phase 3]
Phase 3 trial comparing immune response and safety of Henogen's adjuvanted Hepatitis B vaccine with Aventis Pasteur MSD's Hepatitis B vaccin…
-
CLINICAL_TRIALS trial_result · 2008-08-28Clinical Trial Update: A Study to Compare the Immune Response and Safety Elicited by Henogen's Adjuvanted Hepatitis B Vaccine Compared to GSK Biologicals Adjuvanted Hepatitis B Vaccine in Pre-Dialysis and Dialysis Patients Who Have Not Been Exposed to Hepatitis B. [Phase 3]
A completed Phase 3 trial comparing Henogen's adjuvanted hepatitis B vaccine with GSK's Engerix-B adjuvanted vaccine in pre-dialysis and dia…
-
CLINICAL_TRIALS trial_result · 2008-08-25Clinical Trial Update: Consistency Study of Three Lots of Henogen's Adjuvanted Hepatitis B Vaccine When Given in 0, 1 Month Schedule [Phase 3]
Phase 3 consistency study evaluating three manufacturing lots of Henogen's adjuvanted hepatitis B vaccine given on a 0 and 1 month schedule;…
-
FDA approval · 2008-07-25FDA Approved: BARACLUDE — Supplemental Application (E.R. Squibb & Sons, L.L.C.)
The FDA approved a supplemental application for BARACLUDE (entecavir) submitted by E.R. Squibb & Sons, L.L.C., indicating an update to its r…
-
FDA label_change · 2008-07-25FDA Approved: BARACLUDE — Supplemental Application (E.R. Squibb & Sons, L.L.C.)
FDA documents a supplemental application for BARACLUDE (entecavir) submitted by E.R. Squibb & Sons, L.L.C., indicating a proposed update to …
-
CLINICAL_TRIALS trial_result · 2008-06-30Clinical Trial Update: A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Patients With Lamivudine Resistant HBeAg-Negative Chronic Hepatitis B. [Phase 4]
A Phase 4 study of PEGASYS (pegylated interferon alfa-2a) in lamivudine-resistant HBeAg-negative chronic hepatitis B was terminated.
-
CLINICAL_TRIALS trial_result · 2008-06-20Clinical Trial Update: Seroprevalence of Hepatitis B Infection and Effect of Booster Response Amongst Taiwanese Young Adults
This clinical trial update reports on the seroprevalence of Hepatitis B infection among Taiwanese young adults and the immune response to a …
-
CLINICAL_TRIALS trial_result · 2008-06-17Clinical Trial Update: Comparing Immunogenicity and Safety of Different Formulations of HBV-MPL Vaccine With Engerix™-B in Adults Aged 19-40 y [Phase 2]
A Phase 2 trial update comparing immunogenicity and safety of different formulations of an HBV-MPL vaccine with Engerix-B in adults aged 19-…
-
CLINICAL_TRIALS trial_result · 2008-06-17Clinical Trial Update: Comparing Immunogenicity and Safety of Different Formulations of HBV-MPL Vaccine With Engerix™-B in Adults Aged 18-40 y [Phase 2]
This Phase 2 study assesses immunogenicity and safety of various HBV-MPL vaccine formulations compared with Engerix-B in adults aged 18-40; …
-
CLINICAL_TRIALS trial_result · 2008-06-17Clinical Trial Update: Evaluation of Immunogenicity, Reactogenicity and Safety of HBV-MPL Vaccine vs Engerix™-B, in Haemodialysis Patients [Phase 1]
Phase 1 trial comparing an HBV-MPL adjuvanted hepatitis B vaccine to Engerix-B in haemodialysis patients assessed immunogenicity, reactogeni…
-
CLINICAL_TRIALS trial_result · 2008-06-16Clinical Trial Update: Immunogenicity and Safety of GSK Biologicals' HBV-MPL Vaccine (2 Doses), and of Engerix™-B (3 Doses) in Healthy Adults [Phase 2]
Phase 2 trial update evaluating immunogenicity and safety of GSK's HBV-MPL vaccine given in 2-dose schedule versus Engerix-B given in a 3-do…
-
CLINICAL_TRIALS trial_result · 2008-06-16Clinical Trial Update: Safety and Immunogenicity of GSK Bio's Candidate HBV-MPL Vaccines Compared to Engerix™-B, in Healthy Adolescents [Phase 2]
Phase 2 clinical trial comparing GSK's HBV-MPL vaccine candidate to Engerix-B in healthy adolescents to evaluate safety and immunogenicity; …
-
CLINICAL_TRIALS trial_result · 2008-06-16Clinical Trial Update: Comparison of Safety, Immuno- and Reactogenicity of MPL-Adjuvanted Recombinant Hepatitis B Vaccine to That of Engerix™-B [Phase 3]
This Phase 3 trial compares the safety, immunogenicity, and reactogenicity of an MPL-adjuvanted recombinant hepatitis B vaccine to Engerix-B…
-
CLINICAL_TRIALS trial_result · 2008-06-16Clinical Trial Update: Immunogenicity and Reactogenicity of MPL Adjuvanted Recombinant Hepatitis B- Vaccine and Engerix™-B in Adult Non-Responders [Phase 3]
Phase 3 clinical trial evaluating the immunogenicity and reactogenicity of an MPL-adjuvanted recombinant Hepatitis B vaccine versus Engerix-…